TRANSCATHETER HEPATIC SEGMENTAL ARTERIAL EMBOLIZATION USING LIPIODOL MIXED WITH AN ANTICANCER DRUG AND GELFOAM PARTICLES FOR HEPATOCELLULAR-CARCINOMA
TRANSCATHETER HEPATIC SEGMENTAL ARTERIAL EMBOLIZATION USING LIPIODOL MIXED WITH AN ANTICANCER DRUG AND GELFOAM PARTICLES FOR HEPATOCELLULAR-CARCINOMA
复制标题
DOI：
10.1007/bf02575465
复制
发表时间：
1990-06-01
影响因子：
2.9
通讯作者：
YOSHIOKA, T
中科院分区：
文献类型：
--
作者：
UCHIDA, H;OHISHI, H;YOSHIOKA, T
对54例肝细胞癌(简称肝癌)患者行经导管肝段动脉化疗栓塞术，其中7例术后切除。在切除的7例中，5例组织学证实完全坏死。未手术死亡47例，节段性碘油栓塞术治疗效果较好。结果表明，该技术不会对正常组织产生不利影响，而且确实增强了TAE的效果。
Transcatheter hepatic segmental arterial chemoembolization using Lipiodol mixed with an anticancer drug followed by the injection of Gelfoam particles, introduced into the tumor-bearing hepatic segment as the target area (segemental Lipiodol-TAE), was carried out in 54 patients with hepatocellular carcinoma (HCC), 7 of whom were later resected. In 5 of the resected 7 cases, complete necrosis was histologically verified. No death due to HCC was encountered in 47 nonoperated cases, and better therapeutic results were obtained with segmental Lipiodol-TAE. It was concluded that this technique does not adversely affect normal tissues, and it does reinforece the effect of TAE.